Correspondence breakpoints recommended by the National Committee for Clinical Laboratory Standards. 8 The MIC 50 s and MIC 90 s of the various antibiotics tested for the 11 ciprofloxacinresistant strains were as follows: penicillin, 2 mg/L and 2 mg/L, respectively; tetracycline, 2 mg/L and 2 mg/L, respectively; ciprofloxacin, 2 mg/L and 2 mg/L, respectively; cefuroxime, 0.5 mg/L and 1 mg/L, respectively; ceftriaxone, 0.03 mg/L and 0.03 mg/L, respectively; and spectinomycin, 8 mg/L and 16 mg/L, respectively. The distributions of PPNG , TR NG , CMR NG PT , CMR NG P and CMR NG T among the 94 isolates are shown in the Table; all but 11 (11.7% ) were resistant to penicillin, tetracycline or both.
6. Clendennen, T. E., Echeverria, P., Saengeur, S., Kees, E. S., Boslego, J. W. & Wignall, F. S. (1992) . Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrobial Agents and Chemotherapy 36, 1682-7.
7. West, B., Changalucha, J., Grosskurth, H., Mayaud, P., Gabone, R. M., Ka-Gina, G. et al. (1995 demonstrated that patients who had received treatment for 5 days with cephalosporins were three times more likely to acquire MR SA than those who had not received one of these agents. They also showed that patients who had been given four antibiotics were 15 times more likely to acquire MR SA than those who had not received any of these drugs. The authors concluded that, as MR SApositive patients had been hospitalized for longer periods than controls, they were more likely both to have received antibiotics and to have acquired MR SA .
The administration to a patient of an antibiotic to which a bacterium is resistant predisposes the patient to colonization by that strain. In the case of MR SA , carriage in the skin folds and anterior nares often precedes the onset of infection. A cquisition of a resistant strain is, therefore, likely to be influenced by the administration of antibiotics that are excreted in high concentrations in sweat. It has recently been demonstrated that ciprofloxacin attains high concentrations in human sweat and promotes colonization of the skin by staphylococci exhibiting resistance to multiple antiobiotics.
2 E limination of the normal skin flora creates a niche which is soon filled by strains tending to be more resistant than the bacteria they have replaced. If MR SA is a particular problem in a hospital, the administration of antibiotics will increase the likelihood of patients becoming colonized with this organism. What has not been determined is precisely how big a role antibiotic administration plays in terms of promoting colonization.
We studied 17 patients newly identified as colonized and/or infected with MR SA (all isolates of which were resistant to ciprofloxacin) and 17 control patients drawn from the same wards. The controls were age-matched within 10 years and had been hospitalized for similar reasons. There was no significant difference between cases and controls in terms of the duration of hospital stay (means of 22.12 days and 20.53 days for controls and MR SA -positive patients respectively) and intravenous lines were present in 15 of 17 patients in both groups. Indwelling urinary catheters were present in 11 (65% ) of patients in the MR SA group and seven (41% ) of those in the control group; this difference is not statistically significant (two-tailed Fisher's exact test, P 0.3). Nine (52.9% ) of the patients in the MR SA group and four (23.5% ) of the controls had received ciprofloxacin; this difference is not significant (P 0.16), but not at the 5% level. Five (29.4% ) of the MR SA patients, but none of the controls, had been given a cephalosporin; this difference is significant at the 5% level ( P 0.04). E ither ciprofloxacin or a cephalosporin had been administered to 14 (82.3% ) of the MR SA patients, compared with only four (23.5% ) of the patients in the control group; this difference is highly significant (P 0.01).
The results of this study demonstrate that the administration of either ciprofloxacin or a cephalosporin is significantly associated with the acquisition of MR SA . In contrast, MR SA carriage was not significantly related to the administration of flucloxacillin (four of 17 MR SApositive patients, compared with five of 17 controls) or co-amoxiclav (seven of 17 MR SA -positive patients, compared with six of 17 controls). It is not clear why some antibiotics to which MR SA strains are resistant influence colonization more than others.
This small pilot study has shown that antibiotic usage promotes colonization and, ultimately, the spread of MR SA in hospital and suggests that limiting the use of cephalosporins and ciprofloxacin is one means of minimizing the selection and dissemination of this bacterium. We are at present undertaking a larger study with the aim of confirming these findings and evaluating the effect of limiting the prescribing of cephalosporins and ciprofloxacin.
A cknowledgement
We Sir, A variety of antimicrobial regimens have been adopted as empirical therapy of febrile neutropenic patients. These regimens tend to reflect the spectra and resistance patterns of the pathogens which predominate in a given institution.
1,2
A ddenbrooke's H ospital is a tertiary referral centre for haematology, oncology and paediatric haematology/ oncology patients. The units on which these three types of patient are managed are separated physically, but are located in the same building. A common antibiotic policy has been in use on the three units since 1992. A ccording to the policy, ciprofloxacin and fluconazole are administered as prophylaxis if the duration of neutropenia (defined as a neutrophil count 0.5 10 9 /L) is expected to exceed 7 days and are continued until the neutrophil count rises above 0.5 10 9 /L; paediatric haematology/oncology patients are also given phenoxymethylpenicillin 4 mg/kg bd. Neutropenic patients who become febrile receive combinations of either azlocillin, gentamicin and vancomycin, ciprofloxacin and benzylpenicillin (if the patient is not already receiving ciprofloxacin as prophylaxis and a central line is not in situ) or ciprofloxacin and vancomycin (if the patient is not already receiving ciprofloxacin as prophylaxis and a central line is in situ). The treatment is reviewed after 72 h and discontinued if there is no obvious site of infection and the blood cultures are sterile. This policy has been evaluated and validated previously. 3 In the present study, we reviewed the bacteraemic episodes in patients on each unit for 1996 in order to determine whether or not the protocol was still appropriate.
